Clinical Trials Browser

Mesothelioma, Malignant × Combined Modality Therapy × 30 days × Clear all

NCT06251310 2026-05-08

SW-682 in Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasmThoracic

Mesothelioma, Malignant